Skip to content

LivaNova LIVN Current Debt

Current Debt at other companies

Abbott logo
AbbottABT
$4.41B+771%
Haemonetics logo
HaemoneticsHAE
$5.02M-98.3%
Medtronic logo
MedtronicMDT
$1.79B-37.8%
ResMed logo
ResMedRMD
$259.93M+2,524%
Novanta logo
NovantaNOVT
$40.42M+733%
Globus Medical logo
Globus MedicalGMED

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.31B+62.8%
Enterprise value$4.11B+58.0%
P/S+0.9×

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's current debt?
LivaNova (LIVN) reported current debt of $121K in Q1 2026.
How has LivaNova's current debt changed year-over-year?
LivaNova's current debt decreased by 99.8% year-over-year, from $78.93M to $121K.
What is the long-term trend for LivaNova's current debt?
Over 5 years (2020 to 2025), LivaNova's current debt has grown at a 29.8% compound annual growth rate (CAGR), from $8.38M to $30.88M.
What does current debt mean?
The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.